This article has been updated with information from Roche's earnings presentation.

NEW YORK (GenomeWeb) – Roche today reported that its 2016 diagnostics revenues grew 6 percent year over year, driven by strong immunodiagnostics product sales within its centralized and point-of-care solutions business.

The company reported CHF 50.58 billion ($51.09 billion) in 2016 revenues, up 5 percent from CHF 48.15 billion in 2015. At constant exchange rates, the firm's revenues grew 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.